Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Inhibitors selection

Dennis, M.S., Lazarus, R.A. Kunitz domain inhibitors of tissue factor-factor Vila. 1. Potent inhibitors selected from libraries by phage display. /. Biol. Chem. 269 22129-22136, 1994. [Pg.372]

The extent to which changes occur in different liquids depends on the type of liquid, type of refining, and whether it has been treated to provide further resistance to oxidation. The stability of liquids can be improved by the addition of oxidation inhibitors. Inhibitors selected to improve stability must be compatible with the other required properties of the liquid. [Pg.602]

Boilers and steam systems Steel steam lines can be inhibited by the use of a volatile amine-based inhibitor such as ammonia, morpholine or cyclohexylamine introduced with the feedwater. It passes through the boiler and into the steam system, where it neutralizes the acidic conditions in pipework. The inhibitor is chemically consumed and lost by physical means. Film-forming inhibitors such as heterocyclic amines and alkyl sulphonates must be present at levels sufficient to cover the entire steel surface, otherwise localized corrosion will occur on the bare steel. Inhibitor selection must take into account the presence of other materials in the system. Some amine products cause corrosion of copper. If copper is present and at risk of corrosion it can be inhibited by the addition of benzotriazole or tolutriazole at a level appropriate to the system (see also Section 53.3.2). [Pg.910]

Inhibition of hematopoietic growth factors Imatinib (Glivec ) is applied to treat chronic myeloid leukemia in Philadelphia-chromosome positive patients. In these patients, translocation of parts of chromosomes 9 and 22 results in the expression of a fusion protein with increased tyrosine kinase activity, called Bcr-Abl. Imatinib is a small Mw inhibitor selective for the tyrosine kinase activity of Bcr-Abl. Thereby, it inhibits the Bcr-Abl induced cell cycle progression and the uncontrolled proliferation of tumor cells. [Pg.411]

Ubiquitous mitochondrial monoamine oxidase [monoamine oxygen oxidoreductase (deaminating) (flavin-containing) EC 1.4.3.4 MAO] exists in two forms, namely type A and type B [ monoamine oxidase (MAO) A and B]. They are responsible for oxidative deamination of primary, secondary, and tertiary amines, including neurotransmitters, adrenaline, noradrenaline, dopamine (DA), and serotonin and vasoactive amines, such as tyramine and phenylethylamine. Their nonselec-tive and selective inhibitors ( selective MAO-A and -B inhibitors) are employed for the treatment of depressive illness and Parkinson s disease (PD). [Pg.783]

Indeed, 5-HT is also a substrate for the 5-HT transporter, itself an important player in the treatment of depression, and more recently for the whole range of anxiety disorders spectrum (GAD, OCD, social and other phobias, panic and post-traumatic stress disorders). It is the target for SSRIs (selective serotonin reuptake inhibitors) such as fluoxetine, paroxetine, fluvoxamine, and citalopram or the more recent dual reuptake inhibitors (for 5-HT and noradrenaline, also known as SNRIs) such as venlafaxine. Currently, there are efforts to develop triple uptake inhibitors (5-HT, NE, and DA). Further combinations are possible, e.g. SB-649915, a combined 5-HTia, 5-HT1b, 5-HT1d inhibitor/selective serotonin reuptake inhibitor (SSRI), is investigated for the treatment of major depressive disorder. [Pg.1124]

There is evidence that protease inhibitors selectively regulate the activity of specific digestive enzymes at the level of gene expression (Rosewicz et al., 1989). Specifically, soybean trypsin inhibitor increases secretion of proteases, including a form of trypsin that is resistant to inhibition but does not cause an increase in amylase secretion. Although the relationships between protease inhibitors and exocrine pancreatic secretion have received the most attention, pancreatic secretion is increased when potato fiber is added to the diet (Jacob et al., 2000), although the mechanism and signaling pathway have not been elucidated. [Pg.166]

Casanola-Martin GM et al. (2006) New tyrosinase inhibitors selected by atomic linear indices-based classification models. Bioorg Med Chem Lett 16(2) 324-330 Tan CY, Wainman D, Weaver DF (2003) N-, alpha-, and beta-substituted 3-amino-propionic acids design, syntheses and antiseizure activities. Bioorg Med Chem 11(1) 113-121... [Pg.96]

G. M. Graham, S. J. Dyer, K. S. Sorbie, W. R. SableroUe, P. Shone, and D. Frigo. Scale inhibitor selection for continuous and downhole squeeze application in HP/HT (high pressure/high temperature) conditions. In Proceedings Volume, pages 645-659. Aimu SPE Tech Conf (New Orleans, LA, 9/27-9/30), 1998. [Pg.398]

Tricyclic antidepressants Monoamine oxidase inhibitors Selective serotonin reuptake inhibitors Antipsychotics Phenothiazines Risperidone Lithium... [Pg.782]

Note These data highlight the need for making comparisons of inhibitor selectivity on the basis of dissociation constants, rather than IC50 values. [Pg.133]

The development of Cat K inhibitors, with an emphasis on the fundamental biology, pharmacology and human clinical trials has been recently reviewed [1-3]. The medicinal chemistry of Cat K inhibitors has also been the subject of recent reviews [7,8]. This article reviews recent publications and meeting abstracts on the design of Cat K inhibitors, as well as developments in Cat K-related biology including animal models for the prediction of inhibitor efficacy, the potential for the separation of bone resorption and formation by Cat K inhibitors, inhibitor selectivity considerations and other potential indications for Cat K inhibitors. [Pg.112]

A series of non-ATP competitive, PH-domain-dependent allosteric inhibitors selective for AKT-1 and AKT-2 have previously been described [34]. Recently, new analogs, such as 22 and 23, were reported as potent and selective AKT-1 and AKT-2 inhibitors with improved aqueous solubility and cell permeability [35]. [Pg.370]

Wang Z., Canagarajah B.J., Boehm J.C., Kassisa S., Cobb M.H., Young P.R., Abdel-Meguid S., Adams J.L., Goldsmith E.J. Structural basis of inhibitor selectivity in MAP kinases. Structure 1998, 6, 1117-1128. [Pg.398]

The group at Millennium Pharmaceuticals has claimed MLN-8054 (97) to be the first kinase inhibitor selective for Aurora-A over Aurora-B, which gives robust inhibition of human tumor xenografts [228-230]. Treatment of cultured human tumor cells with 97 resulted in the accumulation of mitotic cells with spindle abnormalities, a phenotype consistent with selective Aurora-A inhibition. In a pharmacodynamic model the time-dependent accumulation of... [Pg.268]

A model for the structural relationship of /V-butyl-1 -deoxynojirimycin (131, Scheme 33) with ceramide, the substrate of ceramide glucosyltransferase, was suggested by Butters and coworkers. They conducted a comparative investigation on a range of 14 derivatives of 1-deoxynojirimycin substituted at the ring nitrogen and/or C-l, as well as 5 pyrrolidine-type inhibitors selected by superpositioning of the iminoalditol with a portion of the ceramide structure.364... [Pg.250]

H. C. Dorfmueller, V. S. Borodkin, M. Schimpl, X. Zheng, R. Kime, K. D. Read, and D. M. F. van Aalten, Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases, Chem. Biol., 17 (2010) 1250-1255. [Pg.292]

Iressa (ZD 1839) is an orally active tyrosine kinase inhibitor selective for the epidermal growth factor (EGF) receptor tyrosine kinase. Iressa is undergoing clinical trials in the treatment of various solid tumors, including head and neck cancer, breast cancer and non-small cell lung cancer. Its antitumor activity is derived from the fact that the EGF receptor and EGF signaling are... [Pg.653]

Over the years, many reversible competitive inhibitors selective for MAO A have been developed, including many a-methylamines. In contrast, very few effective MAO B-selective reversible inhibitors have been reported to date. Accumulated experience has indicated that a-alkylamines are inhibited steiically from binding to MAO B—and thus are MAO A selective. No complementary steric inhibition selective for MAO A is available [6b]. However, it was demonstrated that, while 5-fluoro-a-methyltryptamine (5) is a selective MAO A substrate, jS-substitution, as in p-chloro-/J-methylphenylamine (6), favors MAO B selectivity [28]. [Pg.666]

Interestingly, fluorination at the 2-position of 1-phenylcyclopropylamine (50), which is known as a selective inhibitor of MAO B relative to MAO A, reversed the selectivity and resulted in a potent inhibitor selective for MAO A [133,134] (Table 5). p-Substituted analogues of 1-phenylcycloropylamine (62b-e, 63b-e) are also MAO A-selective inhibitors and showed the same level of inhibitory potency as 62a and 63a. [Pg.687]

PEE-IV Inhibitors Selective inhibitors of phosphodiesterase IV (PDE4) are in development for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Two of them contain fluorine atoms roflumilast (preregistered) bears a difluoromethyl ether and AWD-12-281 (Phase II) has a single fluorine atom (Figure 8.51). [Pg.315]

Mechanism of Action An antiviral that acts as an HIV-1 protease inhibitor, selectively preventing the processing of viral precursors found in cells infected with HIV-1. Therapeutic Effect Prevents the formation of mature HIV cells. [Pg.93]

Creation of an optimum composition of modifiers (promoters, inhibitors, selective poisons, etc.) ... [Pg.310]

Monoamine oxidase (MAO) inhibitors, selective (Type A) moclobemide... [Pg.621]

Two classes of antidepressants act as combined serotonin and norepinephrine reuptake inhibitors selective serotonin-norepinephrine reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs). [Pg.653]

SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS Selective Serotonin-Norepinephrine Reuptake Inhibitors... [Pg.658]


See other pages where Inhibitors selection is mentioned: [Pg.400]    [Pg.318]    [Pg.1502]    [Pg.98]    [Pg.472]    [Pg.172]    [Pg.231]    [Pg.276]    [Pg.278]    [Pg.359]    [Pg.107]    [Pg.343]    [Pg.374]    [Pg.286]    [Pg.314]    [Pg.671]    [Pg.688]    [Pg.589]    [Pg.619]    [Pg.262]    [Pg.273]    [Pg.318]   
See also in sourсe #XX -- [ Pg.88 ]




SEARCH



5-HT-selective reuptake inhibitors

A Selective serotonin re-uptake inhibitors (

Allosteric sites, inhibitor selectivity

And selective serotonin receptor inhibitors

Antidepressants Monoamine oxidase inhibitors Serotonin-selective

Antidepressants selective noradrenaline reuptake inhibitor

Antidepressants selective norepinephrine reuptake inhibitors

Antidepressants selective serotonin inhibitors

Antidepressants selective serotonin reuptake inhibitors

Antipsychotic drugs selective serotonin reuptake inhibitors with

Anxiety selective serotonin reuptake inhibitors

Attention deficit disorder selective norepinephrine reuptake inhibitors

COX2 selective inhibitors

Chemical inhibitors, selection

Corrosion inhibitors selection

Cyclooxygenase-2 Selective Inhibitors

Cyclooxygenase-2 inhibitors selectivity

Dasatinib inhibitor selectivity

Depression selective noradrenaline reuptake inhibitors

Depression selective serotonin reuptake inhibitors

Depressive disorders selective serotonin reuptake inhibitors

Development of Selective COX-2 Inhibitors

Dihydrofolate reductase inhibitors selective toxicity

Dopamine- selective reuptake inhibitors

EGFR (epidermal growth factor inhibitor selectivity

ErbB selective inhibitors

Gefitinib inhibitor selectivity

Hormonal) Selective serotonin re-uptake inhibitors (

Identification of Selective Inhibitors

Imatinib inhibitor selectivity

Inhibitors Selectivity

Inhibitors norepinephrine-selective contrasted

Inhibitors target selection

Insomnia selective serotonin reuptake inhibitors

Lapatinib inhibitor selectivity

Look up the names of both individual drugs and their drug groups to access full information Selective serotonin re-uptake inhibitors (

Medications selective serotonin reuptake inhibitors

Metabolic inhibitor selectivity

Mirtazapine selective serotonin reuptake inhibitors with

Monoamine oxidase inhibitors selective

Monoamine oxidase inhibitors selective irreversible

NSAIDs) Selective serotonin re-uptake inhibitors (

Nausea selective serotonin receptor inhibitors

Nefazodone selective serotonin reuptake inhibitors with

Non-selective Monoamine Reuptake Inhibitor

Nonsteroidal anti-inflammatory drugs selective cyclooxygenase-2 inhibitors

Obsessive-compulsive disorder selective serotonin reuptake inhibitors

PI3K-selective inhibitors

Panic disorder selective serotonin reuptake inhibitors

Phosphodiesterase inhibitors selective

Posttraumatic stress disorder selective serotonin reuptake inhibitors

Protein kinase family inhibitor selectivity

Protein synthesis inhibitors selective action

Protein target isoform selective inhibitor

Reboxetine selective serotonin reuptake inhibitors with

Schizophrenia Selective serotonin reuptake inhibitors

Selected serotonin reuptake inhibitors

Selection of Inhibitor

Selective Biochemical Inhibitors

Selective COX-2 inhibitors

Selective Inhibitors of Cyclooxygenase-2 (COX

Selective Serotonin-Norepinephrine Reuptake Inhibitors

Selective Serotonine Reuptake Inhibitors

Selective cholesterol absorption inhibitors

Selective dissolving solubility inhibitors

Selective inhibitor

Selective inhibitor

Selective noradrenaline reuptake inhibitors

Selective noradrenergic reuptake inhibitors

Selective norepinephrine reuptake inhibitors

Selective norepinephrine reuptake inhibitors action

Selective norepinephrine reuptake inhibitors depression

Selective norepinephrine reuptake inhibitors efficacy

Selective norepinephrine reuptake inhibitors response

Selective norepinephrine reuptake inhibitors side effects

Selective pyrrolidine inhibitors

Selective serotonin and norepinephrine reuptake inhibitors

Selective serotonin inhibitors

Selective serotonin re-uptake inhibitors

Selective serotonin re-uptake inhibitors SSRIs)

Selective serotonin receptor inhibitor (SSRI

Selective serotonin reuptake inhibitor behavioral

Selective serotonin reuptake inhibitor metabolic

Selective serotonin reuptake inhibitors

Selective serotonin reuptake inhibitors (SSRIs side effects

Selective serotonin reuptake inhibitors . See

Selective serotonin reuptake inhibitors Citalopram Fluoxetine

Selective serotonin reuptake inhibitors Fluvoxamine Paroxetine Sertraline

Selective serotonin reuptake inhibitors MAOIs

Selective serotonin reuptake inhibitors MDMA)

Selective serotonin reuptake inhibitors SSRIs)

Selective serotonin reuptake inhibitors about

Selective serotonin reuptake inhibitors action

Selective serotonin reuptake inhibitors administration

Selective serotonin reuptake inhibitors adverse effects

Selective serotonin reuptake inhibitors alprazolam

Selective serotonin reuptake inhibitors amphetamines

Selective serotonin reuptake inhibitors analysis

Selective serotonin reuptake inhibitors and

Selective serotonin reuptake inhibitors anxiety disorders

Selective serotonin reuptake inhibitors anxiety from

Selective serotonin reuptake inhibitors anxiety with

Selective serotonin reuptake inhibitors anxiolytics

Selective serotonin reuptake inhibitors benzodiazepines

Selective serotonin reuptake inhibitors buspirone

Selective serotonin reuptake inhibitors characteristics

Selective serotonin reuptake inhibitors chemical structures

Selective serotonin reuptake inhibitors children

Selective serotonin reuptake inhibitors citalopram

Selective serotonin reuptake inhibitors classification

Selective serotonin reuptake inhibitors clinical trials

Selective serotonin reuptake inhibitors clozapine

Selective serotonin reuptake inhibitors death

Selective serotonin reuptake inhibitors depression from

Selective serotonin reuptake inhibitors discontinuation

Selective serotonin reuptake inhibitors discontinuation syndrome

Selective serotonin reuptake inhibitors dosing

Selective serotonin reuptake inhibitors drug administration

Selective serotonin reuptake inhibitors drug interactions

Selective serotonin reuptake inhibitors drug overdose

Selective serotonin reuptake inhibitors drug withdrawal

Selective serotonin reuptake inhibitors drugs

Selective serotonin reuptake inhibitors during pregnancy

Selective serotonin reuptake inhibitors effects

Selective serotonin reuptake inhibitors efficacy

Selective serotonin reuptake inhibitors enantiomers

Selective serotonin reuptake inhibitors enhanced

Selective serotonin reuptake inhibitors escitalopram

Selective serotonin reuptake inhibitors extended-release

Selective serotonin reuptake inhibitors fluoxetine

Selective serotonin reuptake inhibitors fluvoxamine

Selective serotonin reuptake inhibitors gastrointestinal

Selective serotonin reuptake inhibitors general

Selective serotonin reuptake inhibitors haloperidol

Selective serotonin reuptake inhibitors hyponatremia with

Selective serotonin reuptake inhibitors immediate

Selective serotonin reuptake inhibitors in children

Selective serotonin reuptake inhibitors in children and adolescents

Selective serotonin reuptake inhibitors in obsessive-compulsive disorder

Selective serotonin reuptake inhibitors indications

Selective serotonin reuptake inhibitors interactions

Selective serotonin reuptake inhibitors labeling

Selective serotonin reuptake inhibitors lactation

Selective serotonin reuptake inhibitors limits

Selective serotonin reuptake inhibitors lithium

Selective serotonin reuptake inhibitors liver

Selective serotonin reuptake inhibitors long-term effects

Selective serotonin reuptake inhibitors mediation

Selective serotonin reuptake inhibitors metabolism

Selective serotonin reuptake inhibitors moclobemide

Selective serotonin reuptake inhibitors monoamine oxidase

Selective serotonin reuptake inhibitors mood disorders from

Selective serotonin reuptake inhibitors nefazodone

Selective serotonin reuptake inhibitors nervous system

Selective serotonin reuptake inhibitors olanzapine

Selective serotonin reuptake inhibitors overdose

Selective serotonin reuptake inhibitors overview

Selective serotonin reuptake inhibitors paroxetine

Selective serotonin reuptake inhibitors pharmacodynamic

Selective serotonin reuptake inhibitors pharmacokinetic

Selective serotonin reuptake inhibitors pharmacology

Selective serotonin reuptake inhibitors pindolol

Selective serotonin reuptake inhibitors risperidone

Selective serotonin reuptake inhibitors second-generation effects

Selective serotonin reuptake inhibitors selectivity differences

Selective serotonin reuptake inhibitors sertraline

Selective serotonin reuptake inhibitors structure

Selective serotonin reuptake inhibitors suicidality from

Selective serotonin reuptake inhibitors toxicity

Selective serotonin reuptake inhibitors tramadol

Selective serotonin reuptake inhibitors trazodone

Selective serotonin reuptake inhibitors tricyclic antidepressant interactions with

Selective serotonin reuptake inhibitors tricyclic antidepressants

Selective serotonin reuptake inhibitors triptans

Selective serotonin reuptake inhibitors venlafaxine

Selective serotonin reuptake inhibitors with stimulants

Selective serotonin reuptake inhibitors withdrawal

Selective serotonin reuptake inhibitors withdrawal from

Selective serotonin reuptake inhibitors, 128 sumatriptan

Selective serotonin uptake inhibitor

Selectivity Searching for Cathepsin K-Selective Inhibitors

Selectivity dioxygenase inhibitors

Selectivity uptake inhibitors

Serotonin reuptake inhibitors, selective dosage

Serotonin reuptake inhibitors, selective interaction with other drugs

Serotonin reuptake inhibitors, selective pharmacokinetics

Serotonin reuptake inhibitors, selective side effects

Social anxiety disorder selective serotonin reuptake inhibitors

Sorafenib inhibitor selectivity

Stainless steels inhibitor selection

Subject selective serotonin reuptake inhibitors

Subtype selective inhibitors

Sunitinib inhibitor selectivity

Synaptosomal Serotonin Uptake and Its Selective Inhibitors (SSRI)

Tissue-selective inhibitor

Trazodone selective serotonin reuptake inhibitors with

Tricyclic antidepressants selective serotonin reuptake inhibitor interactions

Vomiting selective serotonin receptor inhibitors

© 2024 chempedia.info